keytruda Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Phase 2 (1)

Interventional (2)

Dana-Farber Cancer Institute (1)
Krystal Biotech, Inc. (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadanticoagulant therapy

I am/have/hadmetastasis

I am/have/hadHER2

I am/have/hadanticoagulants

I am/have/hadbrain metastases

I am/have/hadinvasive breast cancer

I am/have/hadtriple-negative breast cancer

I am/have/hadtubal ligation

I am/have/hadgilbert's syndrome

I am/have/hadtriple negative breast neoplasms

I am/have/hadstage iv breast cancer

I am/have/hadaptt

I am/have/hadprogesterone

I am/have/hadcns disease

I am/have/hadcentral nervous system disorder

I am/have/hadneutrophil count

I am/have/hadalopecia

I am/have/hadhair thinning

I am/have/hadneuropathy

I am/have/hadliver metastasis

added new label for I am/have/had

more

I am looking for

I am looking forpembrolizumab

I am looking formk-3475

I am looking foranticoagulants

I am looking forkeytruda

I am looking forcopper

I am looking forsacituzumab govitecan

I am looking foradjuvant

I am looking forimmunomodulators

I am looking forcorticosteroids

I am looking forbisphosphonate

I am looking forimmunostimulant

I am looking forprogesterone

I am looking foririnotecan

I am looking forestrogen

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

metastasis

anticoagulant therapy

pembrolizumab

anticoagulants

brain metastases

8 views
05 Aug, 2020

Phase 1
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs (KYANITE-1)

Subjects in Cohorts 5 and 6 are receiving inhaled KB707 once every 2 weeks (q2w), delivered in combination with Keytruda once every 6 weeks. Subjects in Cohort 7 are receiving inhaled KB707 in combination with docetaxel once every 3 weeks.All subjects will be treated until tumor progression, death, unacceptable toxicity, …

0 views
12 Dec, 2025

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.